126 related articles for article (PubMed ID: 32074003)
1. Re: CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30
Richie JP
J Urol; 2020 May; 203(5):883-884. PubMed ID: 32074003
[No Abstract] [Full Text] [Related]
2. CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30
Hong LK; Chen Y; Smith CC; Montgomery SA; Vincent BG; Dotti G; Savoldo B
Cancer Immunol Res; 2018 Oct; 6(10):1274-1287. PubMed ID: 30087115
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a chimeric T-cell receptor with specificity for the Hodgkin's lymphoma-associated CD30 antigen.
Hombach A; Heuser C; Sircar R; Tillmann T; Diehl V; Pohl C; Abken H
J Immunother; 1999 Nov; 22(6):473-80. PubMed ID: 10570745
[TBL] [Abstract][Full Text] [Related]
4. Loss of CD30 expression in metastatic embryonal carcinoma: the effects of chemotherapy?
Berney DM; Shamash J; Pieroni K; Oliver RT
Histopathology; 2001 Oct; 39(4):382-5. PubMed ID: 11683938
[TBL] [Abstract][Full Text] [Related]
5. Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes.
Ramos CA; Ballard B; Zhang H; Dakhova O; Gee AP; Mei Z; Bilgi M; Wu MF; Liu H; Grilley B; Bollard CM; Chang BH; Rooney CM; Brenner MK; Heslop HE; Dotti G; Savoldo B
J Clin Invest; 2017 Sep; 127(9):3462-3471. PubMed ID: 28805662
[TBL] [Abstract][Full Text] [Related]
6. Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30
Wang D; Zeng C; Xu B; Xu JH; Wang J; Jiang LJ; Wang QX; Li CR; Wang N; Huang L; Zhang YC; Xiao Y; Zhou JF
Blood Cancer J; 2020 Jan; 10(1):8. PubMed ID: 31974371
[No Abstract] [Full Text] [Related]
7. CD30 expression in seminoma.
Hittmair A; Rogatsch H; Hobisch A; Mikuz G; Feichtinger H
Hum Pathol; 1996 Nov; 27(11):1166-71. PubMed ID: 8912826
[TBL] [Abstract][Full Text] [Related]
8. CD30 and its ligand: possible role in regulation of teratoma stem cells.
Pera MF; Bennett W; Cerretti DP
APMIS; 1998 Jan; 106(1):169-72; discussion 173. PubMed ID: 9524575
[TBL] [Abstract][Full Text] [Related]
9. Chimeric antigen receptor T-cell therapy targeting CD30 in Hodgkin lymphoma.
Savoldo B
Clin Adv Hematol Oncol; 2021 Jan; 19(1):24-26. PubMed ID: 33493145
[No Abstract] [Full Text] [Related]
10. Brentuximab-vedotin maintenance following chemotherapy without irradiation for primary intracranial embryonal carcinoma in down syndrome.
Abu Arja MH; Conley SE; Salceda V; Al-Sufiani F; Boué DR; Finlay JL
Childs Nerv Syst; 2018 Apr; 34(4):777-780. PubMed ID: 29236132
[TBL] [Abstract][Full Text] [Related]
11. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors.
Lee SY; Park CG; Choi Y
J Exp Med; 1996 Feb; 183(2):669-74. PubMed ID: 8627180
[TBL] [Abstract][Full Text] [Related]
12. Expression in cytotoxic T lymphocytes of a single-chain anti-carcinoembryonic antigen antibody. Redirected Fas ligand-mediated lysis of colon carcinoma.
Darcy PK; Kershaw MH; Trapani JA; Smyth MJ
Eur J Immunol; 1998 May; 28(5):1663-72. PubMed ID: 9603473
[TBL] [Abstract][Full Text] [Related]
13. Expression and a role of CD30 in regulation of T-cell activity.
Tarkowski M
Curr Opin Hematol; 2003 Jul; 10(4):267-71. PubMed ID: 12799531
[TBL] [Abstract][Full Text] [Related]
14. CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma.
Pohl C; Denfeld R; Renner C; Jung W; Bohlen H; Sahin U; Hombach A; van Lier R; Schwonzen M; Diehl V
Int J Cancer; 1993 Jul; 54(5):820-7. PubMed ID: 7686889
[TBL] [Abstract][Full Text] [Related]
15. CD30 signals integrate expression of cytotoxic effector molecules, lymphocyte trafficking signals, and signals for proliferation and apoptosis.
Muta H; Boise LH; Fang L; Podack ER
J Immunol; 2000 Nov; 165(9):5105-11. PubMed ID: 11046041
[TBL] [Abstract][Full Text] [Related]
16. CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Kadin ME; Morgan J; Xu H; Glicksman CA
Aesthet Surg J; 2017 Jul; 37(7):771-775. PubMed ID: 28402493
[TBL] [Abstract][Full Text] [Related]
17. CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule.
Latza U; Foss HD; Dürkop H; Eitelbach F; Dieckmann KP; Loy V; Unger M; Pizzolo G; Stein H
Am J Pathol; 1995 Feb; 146(2):463-71. PubMed ID: 7856755
[TBL] [Abstract][Full Text] [Related]
18. CD30 is involved in inhibition of T-cell proliferation by Hodgkin's Reed-Sternberg cells.
Su CC; Chiu HH; Chang CC; Chen JC; Hsu SM
Cancer Res; 2004 Mar; 64(6):2148-52. PubMed ID: 15026356
[TBL] [Abstract][Full Text] [Related]
19. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma.
Jones TD; Ulbright TM; Eble JN; Baldridge LA; Cheng L
Am J Surg Pathol; 2004 Jul; 28(7):935-40. PubMed ID: 15223965
[TBL] [Abstract][Full Text] [Related]
20. Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice.
Amakawa R; Hakem A; Kundig TM; Matsuyama T; Simard JJ; Timms E; Wakeham A; Mittruecker HW; Griesser H; Takimoto H; Schmits R; Shahinian A; Ohashi P; Penninger JM; Mak TW
Cell; 1996 Feb; 84(4):551-62. PubMed ID: 8598042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
